Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease

Hormone receptor positive (HR+) breast cancers are a heterogeneous class with differential prognosis. Although more than half of Indian women present with advanced disease, many such patients do well. We have attempted identification of biologically indolent tumors within HR+HER2- tumors based on ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Prabhu, Jyothi S, Korlimarla, Aruna, Anupama, C E, Alexander, Annie, Raghavan, Rohini, Kaul, Roma, Desai, Krisha, Rajarajan, Savitha, Manjunath, Suraj, Correa, Marjorrie, Raman, R, Kalamdani, Anjali, Prasad, MSN, Patil, Shekar, Gopinath, K S, Srinath, B S, Sridhar, T.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506875/
https://www.ncbi.nlm.nih.gov/pubmed/28704710
http://dx.doi.org/10.1016/j.tranon.2017.04.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506875/
https://www.ncbi.nlm.nih.gov/pubmed/28704710
http://dx.doi.org/10.1016/j.tranon.2017.04.011

Ejemplares similares